References
- Mitchell DM, Spitz PW, Young DV, et al. Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum 1986: 29: 706–14
- Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984: 27: 864–72
- Pincus T, Callahan LF. Taking mortality in rheumatoid arthritis seriously: predictive markers, socioeconomic status and comorbidity. J Rheumatol 1986: 13(5): 841–5
- Pincus T. Is mortality increased in rheumatoid arthritis? J Musculoskel Med 1988: 5(6): 27–46
- Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: a 75 year prospective follow up. J Rheumatol 1984: 11: 158–61
- Harris ED Jr. Emkey RD, Nichols JE, et al Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983: 10(5): 713–21
- Pugh MC, Pugh CB. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis. Clin Pharm 1987: 6(6): 475–91
- Melnyk V. Geriatric rheumatology: safe use of potentially toxic antirheumatics. Geriatrics 1988: 43(7): 83–7, 90
- Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986: 29(7): 822–31